The reply

Am J Med. 2014 Aug;127(8):e19. doi: 10.1016/j.amjmed.2014.04.027.

Authors

Takako Kurata¹, Daiki Kanbayashi¹, Jun Komano², Tesuo Kase¹, Kazuo Takahashi¹

Affiliations

¹ Osaka Prefectural Institute of Public Health, Osaka, Japan.
² Osaka Prefectural Institute of Public Health, Osaka, Japan; National Hospital Organization Nagoya Medical Center, Nagoya, Japan.

PMID: 25107393
DOI: 10.1016/j.amjmed.2014.04.027

No abstract available

Publication types

Letter
Comment

MeSH terms

Humans
Male
Measles / virology*
Measles Vaccine / adverse effects*

Substances

Measles Vaccine